|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4 CAD | +11.11% |
|
+1.27% | -17.53% |
| Apr. 26 | BioNxt Solutions Inc. Announces ODF Cladribine Update | CI |
| Apr. 26 | BioNxt Solutions Inc. announced that it expects to receive CAD 1.62 million in funding | CI |
BioNxt Solutions Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CAD 0.169645 million compared to CAD 0.121426 million a year ago. Net loss was CAD 1.5 million compared to CAD 1.76 million a year ago.
Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.53% | 32M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
BIONXT SOLUTIONS INC. 
